---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-031649"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:27:35.171737+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InfuSystem Q1 net rev $33.7M (-3% YoY); net income $1.0M vs prior loss

## Summary
- Patient Services rev $22.1M (+6% YoY); wound care revenue more than doubled to $2.1M.
- Device Solutions rev $11.6M (-17% YoY) due to GE Healthcare contract restructure.
- Gross margin expanded to 58.4% from 55.2%; adjusted EBITDA $6.4M (18.9% margin).
- Full-year 2026 guidance reaffirmed: pro-forma net rev growth 6-8%, adj EBITDA margin mid-to-low 20%.
- Repurchased $856k of common stock; liquidity $57.1M; new ERP went live March 1, 2026.

## SEC filing metadata
- accession: 0001628280-26-031649
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828026031649/0001628280-26-031649-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828026031649/infu-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-031649
- JSON: https://secwatch.observer/filing/0001628280-26-031649.json
- Plain text: https://secwatch.observer/filing/0001628280-26-031649.txt

## Source-grounded claims
- claim_id: c0d2bb813206044a958aa05e20a56093c8b9af54
  claim: InfuSystem Holdings, Inc reported first quarter ended March 31, 2026 results: revenue $33.7 million, net income $1.0 million, or $0.05 per diluted share, EPS $0.05 per diluted share. Guidance reaffirmed.
  evidence_excerpt: InfuSystem Announces Financial Results for First Quarter 2026 Net Revenues of $33.7 million Representing a 3% Reduction from the Prior Year Net income of $1.0 million Adjusted EBITDA (non-GAAP) of $6.4 million Adjusted EBITDA (non-GAAP) margin expanded by 1% to 19% Reaffirms Full-Year 2026 Guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1337013/000162828026031649/0001628280-26-031649-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.